Speakers

Alain Huriez

Chairman and Managing Partner

Adbio Partners

Mr Alexander Zehnder

CEO

CureVac

Dan Staner

Chief Business Officer

ALCEDIAG

Ms Evy Reviers

Chairwoman

EUpALS

James Hamilton

Chief of Discovery & Translational Medicine

Arrowhead Pharmaceuticals

Mr Jean-François Toussaint

Global Head of R&D Vaccines

Sanofi

Lawrence Thompson

Associate Research Fellow

Pfizer

Marianne Mertens

Partner

Apollo Health Ventures

Marie Wikstrom-Lindholm

CSO

Silence Therapeutics

Mr Michael Hodges

CEO

1Strand

Morten Lindow

Co-founder & Snr Lead RNAHub

Roche

Ms Myriam Mendila

Chief Scientific Officer

CureVac

Pad Chivukula

CSO

Arcturus Therapeutics

Paul Nioi

SVP

Alnylam Pharmaceuticals

Richard Klar

CRO

Secarna

Mr Said Francis

Chief Business Officer

Moderna

Shalini Andersson

Vice President of Oligonucleotide Discovery

AstraZeneca

Ms Shirley Hopper

Deputy Director National Licensing Strategy

MHRA

Tamar Grossman

VP, Global Head of RNA, Gene Therapy and Delivery

Johnson & Johnson Innovative Medicine

Ulrik Lytt Rahbek

VP of Partnerships RNA and Gene Therapies

Novo Nordisk

Karina Thorn

Corporate Vice President, Head of Research, Global Nucleic Acid Therapies Research

Novo Nordisk

Ms Sofia Adolfsson

Scientific Officer and Head of Bioinformatics

TATAA Biocenter

Sudhir Agrawal

President and Founder

Arnay Sciences

Balasubramanian Arumugam

Director

Asymchem

Mr Julien Barteau

Group Leader

UCL

Marcel Blommers

CSO

Saverna Therapeutics

Bhawanjit Brar

CEO

Jaan Biotherapeutics

Leigh Brody

Investment Manager

Albion VC

Bao Cai

Executive Director, Process Development

Sarepta Therapeutics

Simone Carneiro

Postdoctoral Fellow

LMU Munich

Mr Mark Dickman

Professor

University of Sheffield

Erik Digman Wiklund

CEO

Circio

Gabriela Ecco

Senior Associate

+ND Capital

Nargisse El Hajjami

Head of Business Development & Strategic Partnerships EMEA

Sartorius

André Gerber

Professor

University of Surrey

Daniel Getts

CEO

Myeloid Therapeutics

Ariane Gomes

CSO

baseimmune

Aurélie Goyenvalle

Director

INSERM

Anne Grahl

Associate

Pureos Bioventures

Trevor Hallam

CSO

Sail Biomedicines

Sophie Hammer

Senior Manager Strategic & Technical Marketing

Evonik

Lorna Harries

CSO

Senisca

Generoso Ianniciello

CBO

Anima Biotech

Mr William Jia

CSO

Virogin Biotech

Ms Natalie Johnston

Principal

4BIO Capital

Marty Koser

Head of Platform Innovation, Global Nucleic Acid Therapies Research

Novo Nordisk

Marek Kozlowski

Senior Investment Director

NRW Ventures

Arun Kumar

RNA Innovations Programs Leader

CEPI

Michael Kyriakides

Partner

Syncona

Frederic Legros

CEO

ARTHEx Biotech

Mr Long-Cheng Li

CEO

Ractigen Therapeutics

Beatriz Llamusi

CSO

Arthex Biotech

Mr Michiel Lodder

CEO

20Med Therapeutics

Harris Makatsoris

Academics Professor of Sustainable Manufacturing Systems

King's College London

Bogdan Mateescu

Group Leader

University of Zürich

Stefan McDonough

Senior Vice President, Head of Neuroscience

Atalanta Therapeutics

Mr Mathew Miller

Director, Life Science and RNA Technology

Codexis

Kemi Olugemo

CMO

Korro Bio

Samir Ounzain

CEO

HAYA Therapeutics

Christopher O’Donnell

Global Head Cardiovascular and Metabolism Translational Medicine

Novartis BioMedical Research

Riccardo Panella

CSO

Resalis Therapeutics

Lijuan Pang

Project Director, Discovery Services

WuXi AppTec

Steve Pascolo

Professor

University Hospital of Zurich

Ms Paola Pozzi

Partner, Sofinnova Telethon Fund

Sofinnova Partners

Hari Pujar

COO

Tessera Therapeutics

Anthony Saleh

CEO

miRecule

Alexander Schwenger

Head of LNP Process Development

Lonza

Attila Seyhan

Director of Translational Oncology Operations at Cancer Center

Brown University

Mr Jesse Smith

CSO

NextRNA Therapeutics

Ms Libby Snell

Director

Oxford Nanopore Technologies

Catello Somma

Partner

Seroba

Mr Thorsten Stafforst

Professor

University Hospital Tübingen

Hiroki Takai

Director, Investment Group

Global Brain

Ms Jenny van Asbeck-van der Wijst

CEO

Mercuna

Manuel Vega

CEO

AGS Therapeutics

Ms Dominique Verhelle

Co-Founder & CEO

NextRNA Therapeutics

Paul Vernooij

Investment Manager

BOM Brabant Ventures

Amy Walker

VP of Research and Business Development

4Basebio

Nathaniel Wang

CEO

Replicate Bioscience

Mr Peter Weinstein

CEO

EmerVax

Michelle Werner

CEO

Alltrna

Jim Weterings

Vice President Research USA, RNA Therapeutics & Delivery

Sirnaomics

Alan Whitmore

CSO

e-therapeutics

Leslie Williams

Co-Founder, President and CEO

hC Bioscience

Renee Williams

Founder and Managing Partner

Williams Biotech Consulting